Variant report
Variant | nsv970322 |
---|---|
Chromosome Location | chr6:6127148-6140491 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs80101569 | chr6:6138800-6138801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563142446 | chr6:6138879-6138880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368620965 | chr6:6138954-6138955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76589387 | chr6:6139020-6139021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9502419 | chr6:6139037-6139038 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs374742210 | chr6:6139050-6139051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17141762 | chr6:6139061-6139062 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs528179309 | chr6:6139064-6139065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185486493 | chr6:6139097-6139098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568147307 | chr6:6139152-6139153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368042202 | chr6:6139172-6139173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs13203617 | chr6:6139270-6139271 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs376791397 | chr6:6139302-6139303 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188518722 | chr6:6139308-6139309 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539384842 | chr6:6139347-6139348 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557926568 | chr6:6139348-6139349 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573003971 | chr6:6139383-6139384 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9504686 | chr6:6139444-6139445 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs145222190 | chr6:6139477-6139478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371970897 | chr6:6139478-6139479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7772158 | chr6:6139569-6139570 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs570127649 | chr6:6139588-6139589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115462372 | chr6:6139595-6139596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
dysmorphism | 22105932 | CNVD |
psychomotor delay | 22105932 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 20688739 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:6138800-6139200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr6:6138800-6139400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr6:6139200-6139400 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
4 | chr6:6139200-6139600 | Enhancers | HUES6 Cell Line | embryonic stem cell |